Dr. Allyson Ocean (@drallysonocean) 's Twitter Profile
Dr. Allyson Ocean

@drallysonocean

MOM ; GI Onc Professor @weillcornell @meyercancer @nyphospital ; Founder @mmfightscrc @letswinpc @oceansblessings ; @JAJForg @curepolg @novocure BOD

ID: 1244837035

linkhttp://www.cornellphysicians.com/aocean calendar_today05-03-2013 23:23:23

9,9K Tweet

7,7K Followers

7,7K Following

Dr. Allyson Ocean (@drallysonocean) 's Twitter Profile Photo

#Electricity has a long history in #medicine. Now, new technologies are expanding how electric fields and pulses could treat diseases from rheumatoid arthritis to #cancer. So proud to be on the board of Novocure! wsj.com/health/healthc… via The Wall Street Journal

Let's Win Pancreatic Cancer 💜 (@letswinpc) 's Twitter Profile Photo

Advancing clarity in NET and #PancreaticCancer care. Join Let's Win, PeerView, and distinguished faculty 👩‍⚕️ 👨‍⚕️ live in Chicago or virtually on 🗓️ May 30. 🔗 bit.ly/2025NET-T

Advancing clarity in NET and #PancreaticCancer care. Join Let's Win, <a href="/PeerView/">PeerView</a>, and distinguished faculty 👩‍⚕️ 👨‍⚕️ live in Chicago or virtually on 🗓️ May 30.
🔗 bit.ly/2025NET-T
Bill Ackman (@billackman) 's Twitter Profile Photo

It has saddened to me watch Harvard University, a university that I love from which I have greatly benefited, self-immolate through gross mismanagement, poor governance, and ideological capture that have occurred over the last 15 or so years, and that have been brought into clear focus

Eyal Yakoby (@eyakoby) 's Twitter Profile Photo

BREAKING: At today’s Harvard graduation, the speaker spent the entire speech attacking Israel and defending a student who assaulted a Jew. This isn’t a one-off. The radicalization at Harvard is systematic, not accidental.

Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

ASCENT04 changes practice w/ improved mPFS 11.2 vs. 7.8 mos; 12 mon PFS 48 vs 33 mos w/ impressive tail suggesting potential for group with durable sustained response; adverse events were not additive. Bonus points for cross over design. #ASCO25 Sara Tolaney OncoAlert

ASCENT04 changes practice w/ improved mPFS 11.2 vs. 7.8 mos; 12 mon PFS 48 vs 33 mos w/ impressive tail suggesting potential for group with durable sustained response; adverse events were not additive. Bonus points for cross over design. #ASCO25 <a href="/stolaney1/">Sara Tolaney</a> <a href="/OncoAlert/">OncoAlert</a>
Oncology Tube (@oncologytube) 's Twitter Profile Photo

🔬 ATOMIC trial follow-up data for dMMR stage III colon cancer🥼 📢 ASCO 2025 Update from Chicago 🏙️ ✅ Atezolizumab + mFOLFOX6 shows sustained 3-yr DFS of 86.4% vs 76.6% with mFOLFOX6 alone (HR: 0.50, p<0.0001). 📰ARTICLE: oncologytube.com/atomic-trial-a… 📺YOUTUBE:

ASCO (@asco) 's Twitter Profile Photo

1st Plenary #ASCO25: #ATOMIC Ph III, adj mFOLFOX + Atezolizumab vs. mFOLFOX in Stg III dMMR colon ca. - 3yr DFS 86.4% vs 76.6% (HR 0.50), benefit seen in all subgroups. DFS 100% in Niche2 - ⬆️ discontinuation w/ Atezo - OS not mature - ⬆️ Gr4 neutropenia - To Adj or to NeoAdj?

1st Plenary #ASCO25: #ATOMIC Ph III, adj mFOLFOX + Atezolizumab vs. mFOLFOX in Stg III dMMR colon ca.

- 3yr DFS 86.4% vs 76.6% (HR 0.50), benefit seen in all subgroups. DFS 100% in Niche2
- ⬆️ discontinuation w/ Atezo
- OS not mature
- ⬆️ Gr4 neutropenia
- To Adj or to NeoAdj?
Bill Ackman (@billackman) 's Twitter Profile Photo

Anti-semitism is like a virus. If it is not shut down at the source — in this case university campuses — it spreads with the help of the media, becomes more virulent, and infects and kills others. Hate does not confine itself to targeting one people. It attacks the smallest

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer NEJM doi.org/10.1056/NEJMoa… 👏Excellent study 👉finally, strong evidence to recommend exercise to our patients 😅Do we need fitness tracker? ESMO - Eur. Oncology EASL Education

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
<a href="/NEJM/">NEJM</a> 
doi.org/10.1056/NEJMoa…
👏Excellent study
👉finally, strong evidence to recommend exercise to our patients
😅Do we need fitness tracker? 
<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/EASLedu/">EASL Education</a>
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

CLDN18.2 expression and efficacy in PDAC: phase I dose expansion cohort with IBI343. #ASCO25 🔎Phs-1: >60% vs <60% 👉ORR 22 vs 0% 👉mPFS 5.5 vs 1.4mo 👉mOS 9.1 vs 6.2 🧐 Looks really promising in >60%, manageable AEs ESMO - Eur. Oncology

CLDN18.2 expression and efficacy in PDAC: phase I dose expansion cohort with IBI343.
#ASCO25
🔎Phs-1: &gt;60% vs &lt;60%
👉ORR 22 vs 0%
👉mPFS 5.5 vs 1.4mo
👉mOS 9.1 vs 6.2
🧐 Looks really promising in &gt;60%, manageable AEs
<a href="/myESMO/">ESMO - Eur. Oncology</a>
Let's Win Pancreatic Cancer 💜 (@letswinpc) 's Twitter Profile Photo

A pancreatic cancer diagnosis can be overwhelming. Our Doctor Finder helps you locate specialists near you - oncologists, surgeons & radiologists who treat the most patients + lead clinical trials. bit.ly/4c4tRBc

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning

Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 
1: Exercise after surgery 
2: Checkpoint inhibitors in the morning